Valuation: Gedeon Richter

Market Cap 2,243B 7.27B 6.35B 5.84B 5.43B 10.33B 693B 10.44B 69.9B 27.22B 340B 27.28B 26.69B 1,177B P/E 2026 *
8.59x
P/E 2027 * 7.88x
Enterprise Value 1,929B 6.25B 5.46B 5.02B 4.67B 8.88B 596B 8.98B 60.1B 23.4B 292B 23.46B 22.95B 1,012B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.78x
Free-Float
72.87%
Yield 2026 *
5.05%
Yield 2027 * 5.4%
1 year 30.92
Extreme 30.925
30.92
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 2017-10-31
Director of Finance/CFO - 2025-04-30
Chief Operating Officer - 2018-12-31
Director TitleAgeSince
Chairman 78 2016-12-31
Chairman 90 2024-02-29
Director/Board Member 65 2012-04-25
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 7.2B
+0.42%+2.68%+14.11%+83.10% 48B
+3.36%+7.21%+72.47%+121.55% 36.89B
+0.97%+2.24%-2.71%+45.66% 12.37B
+0.64%+4.22%+14.68%+96.22% 11.95B
+0.38%+1.56%+34.19%+121.19% 9.01B
+1.22%+2.99%+54.53%-6.03% 7.05B
-0.62%+32.11%-16.02%+21.06% 6.58B
+2.71%+5.41%+24.07%+242.00% 6.55B
+1.42%+6.07%+25.15%+134.61% 4.36B
Average +3.49%+5.43%+24.50%+95.48% 15.86B
Weighted average by Cap. +2.48%+3.88%+30.45%+94.90%

Financials

2026 *2027 *
Net sales 952B 3.08B 2.69B 2.48B 2.31B 4.38B 294B 4.43B 29.66B 11.55B 144B 11.57B 11.32B 499B 1,024B 3.32B 2.9B 2.67B 2.48B 4.71B 316B 4.76B 31.89B 12.42B 155B 12.45B 12.18B 537B
Net income 259B 840M 735M 676M 628M 1.19B 80.17B 1.21B 8.09B 3.15B 39.34B 3.16B 3.09B 136B 286B 927M 810M 745M 693M 1.32B 88.42B 1.33B 8.92B 3.47B 43.39B 3.48B 3.4B 150B
Net Debt -315B -1.02B -891M -820M -762M -1.45B -97.2B -1.46B -9.8B -3.82B -47.7B -3.83B -3.74B -165B -421B -1.36B -1.19B -1.1B -1.02B -1.94B -130B -1.96B -13.13B -5.11B -63.89B -5.12B -5.01B -221B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,300.00HUF
Average target price
12,931.29HUF
Spread / Average Target
+5.13%

Quarterly revenue - Rate of surprise